ArticleTherapeutic advances in hematology2026

Twelve-month follow-up of a real-world, noninterventional study evaluating the impact of emicizumab on bleeding episodes, joint health, and quality of life in people with hemophilia A.

Anupam Dutta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.